On January 30, 2015, the 6th subject was enrolled in our ongoing study of MDMA-assisted therapy for social anxiety in 12 adults on the autism spectrum. This study, which is now halfway through enrollment, is exploring whether MDMA combined with therapy can enhance functional skills and quality of life in autistic adults with social anxiety. Principal Investigator Charles Grob, M.D., who is leading the study with co-investigator Alicia Danforth, Ph.D., appeared on KCRW/NPR’s February 6 episode of “To the Point” to share his views on the resurgence of research into the risks and therapeutic benefits of psychedelics. MAPS is sponsoring this collaborative study in association with researchers at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center and Stanford University.
